NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,247,338 | +180.9% | 22,063 | +125.5% | 0.80% | +147.7% |
| Q3 2021 | $800,000 | -11.9% | 9,782 | -1.7% | 0.32% | -17.1% |
| Q2 2021 | $908,000 | +9.1% | 9,952 | +2.3% | 0.39% | -4.2% |
| Q1 2021 | $832,000 | -5.2% | 9,730 | +4.7% | 0.41% | -15.8% |
| Q4 2020 | $878,000 | +14.5% | 9,293 | +5.4% | 0.49% | +2.1% |
| Q3 2020 | $767,000 | +1.2% | 8,816 | +1.6% | 0.48% | -9.0% |
| Q2 2020 | $758,000 | +8.3% | 8,674 | +2.2% | 0.52% | -10.4% |
| Q1 2020 | $700,000 | -57.6% | 8,487 | -50.5% | 0.58% | -54.2% |
| Q1 2019 | $1,649,000 | +13.9% | 17,150 | +1.6% | 1.28% | -3.3% |
| Q4 2018 | $1,448,000 | -2.3% | 16,873 | -1.9% | 1.32% | +18.3% |
| Q3 2018 | $1,482,000 | +12.9% | 17,206 | -1.0% | 1.12% | +4.2% |
| Q2 2018 | $1,313,000 | -13.5% | 17,380 | -7.4% | 1.07% | -16.4% |
| Q1 2018 | $1,518,000 | -2.3% | 18,774 | +1.4% | 1.28% | -12.0% |
| Q4 2017 | $1,554,000 | – | 18,511 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |